Skip to main content

International Journal of Clinical Oncology

Ausgabe 9/2023

Inhalt (15 Artikel)

Review Article

The efficacy of albumin–globulin ratio to predict prognosis in cancer patients

Will S. Roberts, William Delladio, Shawn Price, Alec Murawski, Hoang Nguyen

Original Article

Effect of a web-based fertility preservation training program for medical professionals in Japan

Masanori Ono, Miyuki Harada, Akihito Horie, Yidan Dai, Itsuko Horiguchi, Eiji Kikuchi, Fuminori Kimura, Tomoe Koizumi, Mitsuru Komeya, Naoki Mizunuma, Kumiko Oseto, Kuniaki Ota, Chikako Shimizu, Kohei Sugimoto, Seido Takae, Emi Takeuchi, Hirotaka Nishi, Yasushi Yumura, Tatsuro Furui, Yasushi Takai, Ken-Ichirou Morishige, Chie Watanabe, Yutaka Osuga, Nao Suzuki

Original Article

The superselective intra-arterial infusion of cisplatin and concomitant radiotherapy (RADPLAT) is effective for metastatic lymph nodes in head and neck squamous cell carcinoma

Satoshi Kano, Takayoshi Suzuki, Daisuke Yoshida, Nayuta Tsushima, Seijiro Hamada, Koichi Yasuda, Yusuke Uchinami, Hidefumi Aoyama, Akihiro Homma

Original Article

Rac1 activation in oral squamous cell carcinoma as a predictive factor associated with lymph node metastasis

Masae Yamazaki, Shoichi Sekikawa, Taiki Suzuki, Satoru Ogane, Kazuhiko Hashimoto, Aya Sasaki, Takeshi Nomura

Original Article

Site of distant metastasis affects the prognosis with recurrent/metastatic head and neck squamous cell carcinoma patients treated with Nivolumab

Yuta Hoshi, Satoshi Shirakura, Masato Yamada, Tomonori Sugiyama, Nobuaki Koide, Satoru Tamii, Kyohei Kamata, Masaru Yokomura, Sotaro Osaki, Takafumi Ohno, Kazuhiro Yagihara, Hiroki Hara, Takeshi Beppu

Original Article

Combined low levels of H4K16ac and H4K20me3 predicts poor prognosis in breast cancer

Bo Wang, Meng Zhou, Xing-li Gan, Yue-xiang Ren, Yuan-zhong Yang, Zi-jin Weng, Xiao-fang Zhang, Jie-xia Guan, Lu-ying Tang, Ze-fang Ren

Original Article

Long-term survival outcome of locally advanced gastric cancer patients who achieved a pathological complete response to neoadjuvant chemotherapy

Feilong Guo, Xiaosong Xiang, Yuhua Huang, Aoxue Chen, Long Ma, Xi Zhu, Zulpikar Abdulla, Wendi Jiang, Jiafei Li, Guoli Li

Open Access Original Article

Phase II clinical trial to study the safety and efficacy of combined S-1 + oxaliplatin therapy as neoadjuvant chemotherapy for locally advanced gastric cancer in older patients

Mitsuhiko Ota, Hiroshi Saeki, Hideo Uehara, Yoshiko Matsuda, Satoshi Tsutsumi, Tetsuya Kusumoto, Hisateru Yasui, Yasunari Ubukata, Shohei Yamaguchi, Hiroyuki Orita, Naoki Izawa, Saburo Kakizoe, Mototsugu Shimokawa, Tomoharu Yoshizumi, Yoshihiro Kakeji, Masaki Mori, Eiji Oki

Original Article

Phase I dose-escalation study on irinotecan, cisplatin, and S-1 combination in chemotherapy-naïve patients with HER2-negative advanced gastric cancer (HERBIS-4B, OGSG 1106)

Hiroki Yukami, Hisato Kawakami, Toshifumi Yamaguchi, Daisuke Sakai, Toshio Shimokawa, Yukinori Kurokawa, Masahiro Goto, Taroh Satoh

Original Article

Morphological response and tumor shrinkage as predictive factors in metastatic colorectal cancer treated with first-line capecitabine, oxaliplatin, and bevacizumab

Tomoyuki Nagaoka, Hiroki Osumi, Teruko Ueno, Akira Ooki, Takeru Wakatsuki, Izuma Nakayama, Mariko Ogura, Daisuke Takahari, Keisho Chin, Kiyoshi Matsueda, Kensei Yamaguchi, Eiji Shinozaki

Original Article

Clinical characteristics of secondary bladder cancer developing after low-/high-dose-rate brachytherapy to treat localized prostate cancer

Keiichiro Miyajima, Hirotaka Suzuki, Fumihiko Urabe, Kosuke Iwatani, Yu Imai, Keiji Yasue, Takafumi Yanagisawa, Shoji Kimura, Kojiro Tashiro, Shunsuke Tsuzuki, Yusuke Koike, Jun Miki, Steffi Yuen, Takaya Sasaki, Manabu Aoki, Shun Sato, Hiroyuki Takahashi, Kenta Miki, Takahiro Kimura

Open Access Original Article

Heterogeneous effects of cytotoxic chemotherapies for platinum-resistant ovarian cancer

Katsuhiko Nara, Ayumi Taguchi, Takehito Yamamoto, Konan Hara, Yuri Tojima, Harunori Honjoh, Akira Nishijima, Satoko Eguchi, Yuichiro Miyamoto, Kenbun Sone, Mayuyo Mori, Tappei Takada, Yutaka Osuga

Original Article

Treatment outcomes of the patient with sinonasal mucosal melanoma: the role of endoscopic resection and postoperative radiotherapy

Nayuta Tsushima, Satoshi Kano, Koichi Yasuda, Takayoshi Suzuki, Seijiro Hamada, Yuji Nakamaru, Masanobu Suzuki, Yusuke Uchinami, Hidefumi Aoyama, Akihiro Homma

Original Article

Prescription patterns of analgesics in cancer patients with bone metastases in Japan: a retrospective database study

Shingo Sato, Hideyuki Tomitori, Atsushi Okawa, Kyoko Akano

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.